{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:32:47Z","timestamp":1790188367617,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.semarthrit.2022.152102","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T09:33:53Z","timestamp":1664098433000},"page":"152102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Sarcoidosis incidence after mTOR inhibitor treatment"],"prefix":"10.1016","volume":"57","author":[{"given":"Matthew C.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emese","family":"V\u00e1g\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Tamang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzs\u00e9bet","family":"Horv\u00e1th-Puh\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.semarthrit.2022.152102_bib0001","article-title":"Sarcoidosis","volume":"358","author":"Bergot","year":"2008","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.semarthrit.2022.152102_bib0002","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2022.152102_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152102_bib0004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152102_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-235372","article-title":"Treatment-recalcitrant laryngeal sarcoidosis responsive to sirolimus","volume":"13","author":"Kelleher","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152102_bib0006","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1111\/j.1432-2277.2011.01256.x","article-title":"Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation","volume":"24","author":"Manzia","year":"2011","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152102_bib0007","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202004-0914IM","article-title":"Successful response to treatment with sirolimus in pulmonary sarcoidosis","volume":"202","author":"Gupta","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152102_bib0008","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1183\/09031936.94.07122255","article-title":"Effective use of cyclosporin in sarcoidosis: a treatment strategy based on computed tomography scanning","volume":"7","author":"O'Callaghan","year":"1994","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152102_bib0009","first-page":"146","article-title":"Evaluation of the efficacy and toxicity of the cyclosporine A-flucortolone-methotrexate combination in the treatment of sarcoidosis","volume":"13","author":"Pia","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152102_bib0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2133.2002.04727.x","article-title":"Cutaneous sarcoidosis successfully treated with topical tacrolimus","volume":"147","author":"Katoh","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2022.152102_bib0011","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2022.152102_bib0012","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"7 Suppl","key":"10.1016\/j.semarthrit.2022.152102_bib0013","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152102_bib0014","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.semarthrit.2022.152102_bib0015","series-title":"US dept of health, education, and welfare, public health service","article-title":"JD. Epidemiologic analysis with a programmable calculator","author":"Rothman","year":"1979"},{"issue":"29","key":"10.1016\/j.semarthrit.2022.152102_bib0016","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1002\/sim.4040","article-title":"Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data","volume":"29","author":"Stijnen","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.semarthrit.2022.152102_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-221915","article-title":"Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study","author":"Khosrow-Khavar","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.152102_bib0018","series-title":"Modern epidemiology","first-page":"758","author":"Rothman","year":"2008"},{"issue":"51","key":"10.1016\/j.semarthrit.2022.152102_bib0019","doi-asserted-by":"crossref","first-page":"39128","DOI":"10.1074\/jbc.M610023200","article-title":"Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152102_bib0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cmet.2011.01.001","article-title":"Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle","volume":"13","author":"Shimizu","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.semarthrit.2022.152102_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2867-7-3","article-title":"Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells","volume":"7","author":"Miller","year":"2007","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.semarthrit.2022.152102_bib0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152102_bib0023","first-page":"471","article-title":"Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases","volume":"26","author":"Toussirot","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152102_bib0024","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Daien","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152102_bib0025","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3899\/jrheum.130278","article-title":"Sarcoidosis induced by tocilizumab: a paradoxical event?","volume":"40","author":"Nutz","year":"2013","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152102_bib0026","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/ijd.14909","article-title":"Tocilizumab-induced sarcoidosis-like reaction in a patient with giant cell arteritis. Clinical implications of a paradoxical phenomenon","volume":"59","author":"Theodosiou","year":"2020","journal-title":"Int J Dermatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:09:11Z","timestamp":1758733751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222001536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":26,"alternative-id":["S0049017222001536"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152102","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcoidosis incidence after mTOR inhibitor treatment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152102"}}